Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Caledonia Investments agrees to sell Stonehage Fleming stake

(Sharecast News) - Caledonia Investments announced an agreement to sell its minority stake in Stonehage Fleming on Tuesday, to US-based Corient Private Wealth, in a deal expected to complete in the first half of 2026, subject to regulatory approvals. The FTSE 250 investment trust first invested in Stonehage Fleming, a leading multi-family office in the EMEA region, in July 2019.

Since then, the business had expanded significantly both organically and through acquisitions, now operating in 14 countries and overseeing more than $175bn in assets.

Caledonia said it expected to receive net cash proceeds of around £288m from the sale, with £251m payable on completion and a further £37m in two equal instalments six and 12 months later.

The proceeds, along with dividends received to date, represented a 3.2-times multiple on Caledonia's original investment cost.

The group said all proceeds would be held on deposit for future investment.

Its stake was valued at £221m as of 31 March 2025.

An additional contingent payment of up to £9m may be made depending on Stonehage Fleming's revenue growth over the three years following completion.

"The Stonehage Fleming team have fully delivered upon our investment thesis which was centred on building scale, international reach and providing additional services to the fast-growing ultra high net worth market," said Tom Leader, Caledonia's head of private capital.

"We are delighted with what Giuseppe, Stuart and the broader Stonehage Fleming team have achieved during our partnership.

"We thank and congratulate them for their stewardship of the business and wish them every success in their new partnership with Corient."

Stonehage Fleming chairman Giuseppe Ciucci added that the firm chose Caledonia as its partner in 2019 because of "their expertise, long-term investment approach, permanent capital and strong alignment to our ambition".

"Working together, the Caledonia team helped us to deliver our strategy and vision, and we are now well positioned for our next phase of growth," Ciucci said.

"We look forward to combining our resources with Corient to create one of the world's leading multi-family offices."

Caledonia said the transaction remained subject to approvals from the UK's Financial Conduct Authority and other international regulators.

At 1217 BST, shares in Caledonia Invesments were up 0.16% at 364.6p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.